Abstract
In 1911, the French dermatologist Louis Queyrat described a sharply defined, bright red, glistening velvety precancerous lesion of the glans penis giving rise to the term ‘erythroplasia of Queyrat’ [1]. In 1978 WHO defined erythroplakia as a “fiery red patch that cannot be characterized clinically or pathologically as any other definable disease” [2]. Bouquot in 1994 updated the definition for erythroplakia as “a chronic red mucosal macule which cannot be given another specific diagnostic name and cannot be attributed to traumatic, vascular, or inflammatory causes” [3]. Erythroplakia and erythroleucoplakia (Speckled leucoplakia) are clinical terms and have no specific histopathologic definition. The correlation between the clinical terminology and pathologic counterparts like hyperplasia, dysplasia and hyperkeratosis are imperfect and that contributes to confusion.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Queyrat L. Erythroplasie de gland. Bull Soc Franc Derm Syph. 1911;22:378–82.
Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007;36:575–80.
Bouquot JE. Oral leukoplakia and erythroplakia: a review and update. Pract Periodontics Aesthet Dent. 1994;6:9–17. quiz 19.
Shafer WG, Waldron CA. Erythroplakia of the oral cavity. Cancer. 1975;36:1021–8.
Lay KM, Sein K, Myint A, Ko SK, Pindborg JJ. Epidemiologic study of 600 villagers of oral precancerous lesions in Bilugyun: preliminary report. Commun Dent Oral Epidemiol. 1982;10:152–5.
Hashibe M, et al. Chewing tobacco, Alcohol, and the risk of erythroplakia mia hashibe cancer epidemiology. Cancer Epidemiol Biomarkers Prev. 2000;9:639–45.
Syrjanen S, et al. Human papillomaviruses in oral carcinoma and oral potentially malignant disorders: a systematic review. Oral Dis. 2011;17(Suppl 1):58–72. https://doi.org/10.1111/j.1601-0825.2011.01792.
Villa A, Villa C, Abati S. Oral cancer and oral erythroplakia: an update and implication for clinicians. Aust Dent J. 2011;56(3):253–6.
Shear M. Erythroplakia of the mouth. Int Dent J. 1972;22(4):460–73.
Jepsen A, Winther JE. Mycotic infection in oral leukoplakia. Acta Odontol Scand. 1965;23:239–56.
Field EA, Field JK, Martin MV. Does candida have a role in oral epithelial neoplasia? J Med Vet Mycol. 1989;27:277–94.
Reichart PA, Philipsen HP. Oral erythroplakia: a review. Oral Oncol. 2005;41(6):551–61.
WHO Collaborating Centre for Oral Precancerous Lesions. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg. 1978;46:518–39.
Pindborg JJ, Reibel J, Holmstrup P. Subjectivity in evaluating oral epithelial dysplasia, carcinoma in situ and initial carcinoma. J Oral Pathol. 1985;14:698–708.
Abbey LM, Kaugars GE, Gunsolley JC, et al. Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol. 1995;80:188–91.
Vered M, Allon I, Dayan D. Maspin, p53, p63, and Ki-67 in epithelial lesions of the tongue: from hyperplasia through dysplasia to carcinoma. J Oral Pathol Med. 2009;38:314–20.
Kurokawa H, Matsumoto S, Murata T, Yamashita Y, Tomoyose T, Zhang M, Fukuyama H, Takahashi T. Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia. J Oral Pathol Med. 2003;32:513–21.
Kannan S, Balaram P, Chandran GJ, Pillai MR, Mathew B, Nalinakumari KR, Nair MK. Differential expression of cytokeratin proteins during tumour progression in oral mucosa. Epithelial Cell Biol. 1994;3(2):61–9.
Wayne S, Robinson RA. Upper aerodigestive tract squamous dysplasia: correlation with p16, p53, pRb, and Ki-67 expression. Arch Pathol Lab Med. 2006;130:1309–14.
Qin G‐Z, et al. A high prevalence of p53 mutations in pre‐malignant oral erythroplakia. Int J Cancer. 1999;80(3):345–8.
Hittelman WN, et al. Early genetic changes during upper aerodigestive tract tumorigenesis. J Cell Biochem. 1993;53(S17F):233–6.
Walsh T, et al. Clinical assessment to screen for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults. Cochrane Database Syst Rev. 2013;(11):CD010173.
Onofre MA, et al. Diagnosis of potentially malignant epithelial lesions. Oral Dis. 1997;3(3):148–52.
Balasundaram I, et al. Is there any benefit in surgery for potentially malignant disorders of the oral cavity? J Oral Pathol Med. 2014;43(4):239–44.
Yang S-W, et al. Clinical characteristics of narrow-band imaging of oral erythroplakia and its correlation with pathology. BMC Cancer. 2015;15(1):1.
Tan NCW, et al. Use of narrow band imaging guidance in the management of oral erythroplakia. Br J Oral Maxillofac Surg. 2011;49(6):488–90.
Mashberg A, Samit A. Early diagnosis of asymptomatic oraland oropharyngeal squamous cancers. CA Cancer J Clin. 1995;45:328–51.
Mashberg A. Erythroplasia: the earliest sign of asymptomatic oral cancer. J Am Dent Assoc. 1978;96:615–20.
Bouquot JE, Ephros H. Erythroplakia: the dangerous red mucosa. Pract Periodontics Aesthet Dent. 1995;7:59–67.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Peter A. Brennan, Tom Aldridge, Raghav C. Dwivedi, Rehan Kazi
About this chapter
Cite this chapter
Parasuraman, L., Bal, M., Pai, P.S. (2019). Erythroplakia and Erythroleucoplakia. In: Brennan, P., Aldridge, T., Dwivedi, R. (eds) Premalignant Conditions of the Oral Cavity. Head and Neck Cancer Clinics. Springer, Singapore. https://doi.org/10.1007/978-981-13-2931-9_5
Download citation
DOI: https://doi.org/10.1007/978-981-13-2931-9_5
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-2930-2
Online ISBN: 978-981-13-2931-9
eBook Packages: MedicineMedicine (R0)